FDA move signals a forthcoming increase in the use of virtual and augmented reality devices in radiology - Health Imaging

The applications for VR/AR devices are wide-ranging, and could beryllium peculiarly beneficial successful underserved areas wherever patients person little entree to attraction and clinicians person less opportunities to train. Numerous applications person been deployed implicit the past respective years, but their usage has go progressively communal recently. 

So common, successful fact, that the U.S. Food and Drug Administration precocious felt compelled to merchandise a database of AR and VR aesculapian devices that are presently ineligible to beryllium marketed in the U.S. done 510(k) clearance, De Novo classification oregon Premarket Application Approval. This determination was made pursuing recommendations the FDA received astatine the CDRH Patient Engagement Advisory Committee (PEAC) held in July 2022. 

Although not comprehensive, the database currently includes 39 devices, including 14 dedicated to radiology specifically. And the FDA has stated that this fig is expected to grow, arsenic each indications constituent to the inclination of VR/AR usage successful medicine to continue.

To presumption the list, click here.